Fetal intervention for congenital diaphragmatic hernia

Area of Science:

• Neonatal Medicine
• Developmental Biology
• Surgical Innovation

Background:

• Congenital diaphragmatic hernia (CDH) is a birth defect caused by incomplete diaphragm formation during embryonic development.
• This defect allows abdominal organs to move into the chest cavity, leading to pulmonary hypoplasia and hypertension, often causing cardiorespiratory failure in newborns.
• Despite advances in neonatal care and extracorporeal membrane oxygenation (ECMO), severe CDH cases still have high mortality and morbidity rates.

Purpose of the Study:

• To review patient selection criteria for fetal intervention in CDH.
• To describe the current Fetoscopic Endoluminal Tracheal Occlusion (FETO) surgical technique for CDH.
• To present early outcomes and discuss ongoing studies related to FETO for CDH.

Main Methods:

• Review of current literature and clinical practices for fetal intervention in CDH.
• Description of the refined Fetoscopic Endoluminal Tracheal Occlusion (FETO) procedure.
• Analysis of early outcomes data from FETO interventions and ongoing clinical trials.

Main Results:

• Fetoscopic Endoluminal Tracheal Occlusion (FETO) is an evolving fetal surgical therapy for severe congenital diaphragmatic hernia (CDH).
• Improved prenatal diagnostics aid in selecting high-risk patients for fetal intervention.
• Early outcomes suggest potential benefits, with ongoing studies evaluating long-term efficacy and safety.

Conclusions:

• Fetoscopic Endoluminal Tracheal Occlusion (FETO) represents a significant advancement in the fetal surgical management of congenital diaphragmatic hernia (CDH).
• Careful patient selection is crucial for optimizing outcomes in fetal intervention for CDH.
• Continued research and clinical trials are essential to further establish the role and refine the technique of FETO in treating severe CDH.